SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis

Loss of SPRY2 and activation of receptor tyrosine kinases are common events in prostate cancer (PC). However, the molecular basis of their interaction and clinical impact remains to be fully examined. SPRY2 loss may functionally synergize with aberrant cellular signalling to drive PC and to promote...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gao, Meiling, Patel, Rachana, Ahmad, Imran, Fleming, Janis, Edwards, Joanne, McCracken, Stuart, Sahadevan, Kanagasabai, Seywright, Morag, Norman, Jim, Sansom, Owen, Leung, Hing Y
Format: Artigo
Langue:Inglês
Publié: WILEY-VCH Verlag 2012
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494076/
https://ncbi.nlm.nih.gov/pubmed/22649008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201100944
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires